Product Description: Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Cindy Orvain, et al. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models. Arthritis Res Ther. 2022 Jan 5;24(1):13.
CAS Number: 2797026-97-0
Molecular Weight: N/A
Compound Purity: 99.27
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: CD28